| Sai Life Sciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 544306 |
NSE Symbol : SAILIFE |
P/E(TTM) : 65.19 |
|
ISIN Demat : INE570L01029 |
Div & Yield% : 0.00 |
EPS(TTM) : 13.43 |
|
Book Value(₹) : 109.56 |
Market Cap(₹Cr) : 18,406.05 |
Face Value(₹) : 1.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,642.05 | 1,418.68 | 1,157.40 | 841.02 | 751.47 |
| Other Income | 37.34 | 29.33 | 27.96 | 28.15 | 27.29 |
| Stock Adjustments | -4.13 | -23.80 | 4.59 | 2.83 | 16.50 |
| Total Income | 1,675.26 | 1,424.21 | 1,189.95 | 872.00 | 795.26 |
| EXPENDITURE : | |||||
| Raw Materials | 445.52 | 408.78 | 413.12 | 251.14 | 232.69 |
| Power and Fuel Cost | 48.19 | 49.49 | 43.73 | 31.86 | 27.25 |
| Other Manufacturing Expenses | 95.35 | 84.73 | 90.06 | 78.21 | 50.32 |
| Selling and Administration Expenses | 135.20 | 117.15 | 84.16 | 84.59 | 85.45 |
| Miscellaneous Expenses | 35.76 | 16.06 | 10.29 | 9.79 | 4.44 |
| Employee Benefit Expenses | 485.56 | 430.63 | 353.76 | 263.37 | 203.64 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 429.69 | 317.37 | 194.84 | 153.03 | 191.46 |
| Interest | 71.94 | 81.15 | 74.38 | 50.98 | 32.11 |
| Gross Profit | 357.75 | 236.22 | 120.46 | 102.05 | 159.35 |
| Depreciation | 126.03 | 107.21 | 87.77 | 79.70 | 71.77 |
| Profit Before Tax | 231.72 | 129.01 | 32.69 | 22.35 | 87.58 |
| Current Tax | 33.82 | 7.97 | 10.73 | 9.37 | 3.73 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 24.44 | 25.81 | -2.28 | -2.70 | 18.55 |
| Reported Net Profit | 173.46 | 95.23 | 24.24 | 15.68 | 65.30 |
| Extraordinary Items | -1.36 | 0.01 | -0.38 | 11.31 | 0.00 |
| Adjusted Net Profit | 174.82 | 95.22 | 24.62 | 4.37 | 65.30 |
| Adjustment below Net Profit | 0.95 | 1.08 | 2.39 | 0.00 | 0.83 |
| Profit/Loss Balance carried down | 594.05 | 497.75 | 478.02 | 461.76 | 394.23 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 6.90 | -0.58 | -0.21 |
| P & L Balance carried down | 768.46 | 594.05 | 497.75 | 478.02 | 460.57 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 383.30 | 396.30 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 38.33 | 39.63 | 0.00 |
| Earnings Per Share-Unit Curr | 8.32 | 53.92 | 13.76 | 8.93 | 36.65 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 104.00 | 572.37 | 517.79 | 507.50 | 486.92 |
| Book Value(Adj)-Unit Curr | 104.00 | - | - | - | - |